University at Buffalo 1977 - 1983
Doctorates, Doctor of Philosophy, Pharmacology
Boston College 1973 - 1977
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Industry Medical Writing Clinical Development Drug Discovery Immunology Scientific Communications Pharmacology Clinical Research Clinical Trials Biotechnology Oncology Drug Development Technology Transfer Publication Planning Biochemistry Medical Communications R&D Medical Affairs Translational Medicine Pharmaceutics Diabetes Product Development Lifesciences Fda Neurology Chemistry Biomarkers Hplc Biologics Therapeutic Areas Medicine Gcp Cro Infectious Diseases Ind Analytical Chemistry Biopharmaceuticals Sop Formulation Validation Hospital Sales Medicinal Chemistry Vaccines 21 Cfr Part 11 Glp Pharmacovigilance Medical Devices Organic Chemistry Osteoporosis Rheumatology
Mental Health Coordinator at Commonwealth of Massachusetts
Location:
Worcester, Massachusetts
Industry:
Mental Health Care
Work:
Commonwealth of Massachusetts - Tewksbury Hospital since Oct 2012
Mental Health Coordinator
Advocates, Inc. Feb 2010 - Sep 2012
Certified Peer Specialist
UMass Medical School - Umass Continuing Care Units Worcester State Hospital Dec 2004 - Sep 2012
Mental Health Counselor
Education:
Worcester State College 1994 - 2004
Bachelor of Science, Philosophy, Communications, Physics, Alternative Energy
Sep 2012 to 2000 Special Education/Head Ice Hockey CoachHand and Stone Massage and Facial SpaMays Landing, NJ May 2011 to Sep 2011Trenton Devils (ECHL) Trenton, NJ Sep 2010 to Apr 2011 Public Relations and Broadcasting
Education:
Richard Stockton College of New Jersey May 2011 Bachelor of Arts in Communications
Name / Title
Company / Classification
Phones & Addresses
Paul Cavanaugh Manager
Encore Healthcare, LLC Skilled Nursing Care Facility Specialty Hospital
8833 Stenton Ave, Ardsley, PA 19038 2158362100
Paul A. Cavanaugh
BALLOONS BY PHONY EXPRESS, LLC
Paul Cavanaugh
PHILIPS HEALTHCARE INFORMATICS, INC
C/O Corporation Service Company, Wilmington, DE 19808 3000 Minuteman Rd, Andover, MA 01810
Paul Cavanaugh Personnel Director
Chestnut Hill Rehab Center LLC Rehabilitation Center
8601 Stenton Ave, Ardsley, PA 19038
Paul Cavanaugh VP Engineering
Franklin Electronic Publishers, Incorporated Book Publishing/Printing & Misc Publishing Wholsale Electronic Parts Mfg Magnetic Disks/Tapes Electronic Computers · Misc Publishing Whol Electronic Parts Mfg Magnetic Disks/Tapes Mfg Electronic Computers Book-Publishing/Printing · Electronic Computers · Computer & Software Merchant Whols
4641 Roosevelt Blvd, Philadelphia, PA 19124 Roosevelt Blvd, Philadelphia, PA 19124 4641 Roosevelt Blvd Ph 800, Philadelphia, PA 19124 2158314600, 2158312600, 2158311560, 2153899260
Paul Cavanaugh Vice President
ATLAS DIAGNOSTICS INTERNATIONAL, INC
Paul Cavanaugh Vice president, Vice Presi, President, Vice President
GENLYTE GROUP INCORPORATED Mfg Coml Light Fixtures Mfg Lighting Equipment · Mfg Coml Light Fixtures · Mfg Commercial Lighting Fixtures Mfg Residential Lighting Fixtures Mfg Lighting Equipment · Manufacture/Sale of Residential & Commer · Provider of Energy Efficient Solid State · Mfg Relays/Industrial Controls · Operates As A Manufacturing of Relays and Industrial Controls In Electric Control Equipment · Mfg Commercial Lighting Fixtures
3000 Minuteman Rd, Andover, MA 01810 200 Franlin Park Dr, Somerset, NJ 08875 2338 W Royal Palm Rd STE J, Phoenix, AZ 85021 10350 Ormsby Park Pl #601, Louisville, KY 40223 8033211185, 7814187900, 2146477880, 5024209500
Alexander L. Weis - Berwyn PA Fred T. Oakes - Rochester NY Frederick H. Hausheer - San Antonio TX Paul F. Cavanaugh - West Chester PA Patricia S. Moskwa - Phoenixville PA
Assignee:
Sterling Drug, Inc. - New York NY
International Classification:
C07H 2100 A61K 31045 A61K 31715 C07C 3120
US Classification:
536 253
Abstract:
Compounds, compositions and methods for inhibiting gene expression are disclosed. The compounds comprise oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini. Preferred diols are polyalkyleneglycols, preferably polyethyleneglycols. Pharmaceutical compositions comprising the compounds and a physiologically acceptable carrier and methods of inhibiting gene expression in mammals comprising administering such compounds are also provided. Methods for inhibiting nuclease cleavage of compounds are also provided.
Alexander Ludvik Weis - Berwyn PA Frederick Herman Hausheer - San Antonio TX Prasad Venkata Chala Chaturvedula - Exton PA Daniel Joseph Delecki - Radnor PA Paul Francis Cavanaugh - West Chester PA Patricia Susan Moskwa - Phoenixville PA Fred Terry Oakes - Rochester NY
Assignee:
Sanofi - Paris
International Classification:
C07H 2104
US Classification:
536 231
Abstract:
The present invention relates to compounds, compositions and methods for inhibiting gene expression. The compounds of this invention comprise 1) oligonucleoside sequences of from about 6 to about 200 bases having a three atom internucleoside linkage or 2) oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini.
Alexander L. Weis - Berwyn PA Fred T. Oakes - Rochester NY Frederick H. Hausheer - San Antonio TX Paul F. Cavanaugh - West Chester PA Patricia S. Moskwa - Phoenixville PA
Assignee:
Sterling Drug, Inc. - New York NY
International Classification:
C07H 2100
US Classification:
536 245
Abstract:
Compounds, compositions and methods for inhibiting gene expression are disclosed. The compounds comprise oligonucleotide sequences of from about 9 to about 200 bases having a diol at either or both termini. Preferred diols are polyalkyleneglycols, preferably polyethyleneglycols. Pharmaceutical compositions comprising the compounds and a physiologically acceptable carrier and methods of inhibiting gene expression in mammals comprising administering such compounds are also provided. Methods for inhibiting nuclease cleavage of compounds are also provided.